Skip to main content
Log in

Uptake of the dopaminergic neurotoxin, norsalsolinol, into PC12 cells via dopamine transporter

  • Molecular Technology
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract.

The uptake of norsalsolinol, a neurotoxin candidate causing parkinsonism-like symptoms, was studied in PC12 cells. The compound was actively taken up by the PC12 cells, with a K m value of 176.2±9.1 µM and a maximum velocity of 55.6±7.0 pmol/min per mg protein; norsalsolinol uptake was dependent on the presence of extracellular Na+. The uptake of norsalsolinol was sensitive to two dopamine transporter inhibitors, GBR-12909 and reserpine, but was less sensitive to desipramine, a noradrenaline transporter inhibitor. Dopamine competitively inhibited norsalsolinol uptake into PC12 cells with a K i value of 271.2±61.6 µM. These results suggest that norsalsolinol is taken up into PC12 cells mainly by the dopamine transporter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maruyama, .Y., Suzuki, .Y., Kazusaka, .A. et al. Uptake of the dopaminergic neurotoxin, norsalsolinol, into PC12 cells via dopamine transporter. Arch Toxicol 75, 209–213 (2001). https://doi.org/10.1007/s002040000202

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002040000202

Navigation